Synthesis of Fluoro Benzothiazoles [1] Comprising Azetidinone Derivatives
Synthesis and Evaluation of Fluoro Benzothiazole Derivatives as Potential Anthelmintic Agents
by Ravish Kumar Chauhan*,
- Published in Journal of Advances in Science and Technology, E-ISSN: 2230-9659
Volume 3, Issue No. 5, May 2012, Pages 0 - 0 (0)
Published by: Ignited Minds Journals
ABSTRACT
Various substituted4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-substituted(1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3-chloro azetidin–2–one containingdifferent functional groups have been synthesized by treatingfluorochloroaniline with KSCN in presence of bromine in glacial acetic acid andammonia to get 2-amino-6-fluoro- 7-chloro-(1,3)-benzothiazole, which wastreated with anthranillic acid in presence of dry pyridine to get 2-amino-N-(6-fluoro-7-chloro-(1,3)-benzothiazol-2-yl) benzamide. To the above, refluxedwith vanillin and alcohol in presence of Conc. HCl to get2-(3-hydroxy-4-methoxy benzylidene amino phenyl amido)-6-fluoro-7-chloro-(1,3)- benzothiazole or Schiff’s base. A Solution of Schiff’s base in 1, 4-dioxanewas added to well-stirred mixture of chloroacetyl chloride and triethylamine toget Azetidinone. To the above product different primary and secondary aromaticamines in presence of DMF were treated to get newly targeted compound throughreplacing at 7th position chlorine. Thelead compounds were characterized by melting point, TLC, calculated elementalanalysis, UV, IR, 1HNMR and MASS spectral studies. The compounds were testedfor anthelmintic activity against earthworms, Perituma posthuma and showed significant activity at low and highconcentration compared to standard; still further studies are requested.
KEYWORD
fluoro benzothiazoles, azetidinone derivatives, synthesis, functional groups, amino phenyl amido, Schiff's base, anthelmintic activity, earthworms, Perituma posthuma, spectral studies
INTRODUCTION
We report here in the new and unreported yet the synthesis of fluoro benzothiazoles [1] comprising azetidinone derivatives. The chemistry and pharmacology of azetidinone have been of great interest because, of its various biological activities in the areas of antimicrobial [2], anti-tuburcular [3], carbonic anhydrase inhibitors [4], local anaesthatics [5], anti-inflammatory [6], anthelmintic [7], anticonvulsant [8], hypoglycemic agents [9] etc, so that the biological and pharmacological activity of thiazolidinone with fluoro benzothiazoles may be taken into account for synergism [10]. It is well known that the introduction of fluorine atom [11] into an organic molecule causes dramatic changes in its biological profile, mainly due to high electro negativity of fluorine, the strong carbon-fluorine bond and increased solubility in lipids. Therefore it was thought worthwhile to synthesize better kinds of drugs by incorporating azetidinone in benzothiazole moiety. In search for new biodynamic potent molecule, it was thought worthwhile to incorporate some additional heterocyclic moieties in the β-lactam nucleus and study their biological and pharmacological activity [12], the review of literature reveal prompted us to synthesize substituted fluorobenzothiazole, azetidinone targeted compounds and those will be screened for anthelmintic activity against earthworms, Perituma posthuma.
CHEMICALS AND REAGENTS
MATERIALS AND METHODS
4-fluoro-3-chloro aniline, Potassium thiocyanate, Glacial acetic acid, Bromine, Anthranillic acid, Pyridine, Vanillin, Ethanol, Conc. Hydrochloric acid, Chloroacetyl chloride, Triethylamine, N,N-dimethyl formamide (DMF), various substituted aniline, morpholine, piperazine and diphenylamine.
EXPERIMENTAL SECTION
Step I: 4-fluoro-3-chloro aniline was treated with potassium thiocyanate (KSCN) in presence of glacial acetic acid and bromine to get 2-amino-6-fluoro-7-chloro-benzothiazole. Step II: 2-amino-6-fluoro-7-chloro-benzothiazole treated with Anthranillic acid in presence of Pyridine to get 2 (o- amino phenyl amido) 6–fluoro -7-chloro (1,3) benzothiazole. Step III: 2 (o-amino phenyl amido) 6–fluoro -7-chloro (1,3) benzothiazole reflexed with vanillin and alcohol in presence of Conc.HCl to get 2 (3-hydroxy-4-methoxy benzylidene amino phenyl amido) 6-fluoro-7-chloro-(1,3) benzothiazole or Schiff’s base.
Available online at www.ignited.in Page 2
Step IV: A Solution of Schiff’s base (0.01 mol) in 1,4-dioxane (50ml) was added to well-stirred mixture of Chloroacetyl Chloride (0.95 ml, 0.012 mol) and Triethylamine (1.08 ml, 0.02 mol) at 0o C. The reaction mixture was then stirred for 18 - 20 hrs and kept aside for 3 days at room temperature. The product was recrystallised from N,N' Dimethyl form amide (DMF). Step V: Azetidine were treated with double the quantities of various substituted aniline, piperazine, diphenyl amine, refluxed for 2 hours in presence of N,N-dimethyl formamide (DMF). The mixture was cooled and poured in to crushed ice. The solid separated was filtered off, dried and crystallized from alcohol and benzene.
Available online at www.ignited.in Page 3
Identification and Characterization
Melting points were determined in open capillaries and are uncorrected. IR spectra (KBr pellet technique) were
recorded using a Perkin-Elmer 237 spectrophotometer. 1H NMR spectra were recorded on Bruker AM 400 instrument (at 400 MHz) using tetramethylsilane (TMS) as an internal standard and DMSO-d6 as a solvent. Chemical shifts are given in parts per million (ppm). Splitting patterns are designated as follows: s- singlet, d- doublet, t- triplet, q- quartet and m-multiplet. Mass spectra (MS) were recorded on Shimadzu GC-MS operating at 70eV. All the synthesized compounds were purified by recrystallization. The reactions were followed up and the purity of compounds was monitored on pre-coated TLC plates and visualizing the spots in ultraviolet light.
4-(m-hydroxy-p-methoxy phenyl) -1 -[(6'-fluoro-7'-o-
nitroanilino (1, 3)-benzothiazol-2'-yl) amido-2-phenyl]-3- chloro azetidin–2–one (A1). Yield 78%; mp 190oC; IR (KBr) ν (cm-1); 3350 (Ar-NH); 1750 (C=0); 1550 (C=N);
1710 C=C); 1450 (NO2); 1130 (C-F); 720 (C–S); 1300
(Sec.Ar.Amine); 840 (C–Cl); 1250 (C-O-C); 1390 (Ar-OH); H NMR (CDCl3) δ 9.5 (s, 1H, -NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.7 (s, 3H, -OCH3); Analysis Calcd. for C30H21O6SN5FCl; C, 56.83%; H, 3.34%; N, 11.05%; Found;
C, 56.81%; H, 3.33%; N, 11.01%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-m-nitroanilino (1, 3)-benzothiazol-2'-yl) amido-2-phenyl]-
3- chloro azetidin–2–one (A2). Yield 82%; mp 178oC; IR (KBr) ν (cm-1); 3370 (Ar-NH); 1710 (C=0); 1525 (C=N);
1680 (C=C); 1450 (NO2); 1160 (C-F); 720 (C–S); 1340
(Sec.Ar.Amine); 840 (C–Cl); 1250 (C-O-C); 1390 (Ar-OH); H NMR (CDCl3) δ 9.6 (s, 1H, -NH-); 9.4 (s, 1H, -NH-); 8.2 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.6 (s, 3H, -OCH3); Analysis Calcd. for C30H21O6SN5FCl; C, 56.83%; H, 3.34%; N, 11.05%; Found;
C, 56.82%; H, 3.32%; N, 11.04%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-p-nitroanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3-
chloro azetidin–2–one (A3). Yield 75%; mp 183oC; IR (KBr) ν (cm-1); 3370 (Ar-NH); 1700 (C=0); 1540 (C=N);
1660 (C=C); 1420 (NO2); 1160 (C-F); 725 (C–S); 1310
(Sec.Ar.Amine); 850 (C–Cl); 1255 (C-O-C); 1380 (Ar-OH); H NMR (CDCl3) δ 9.6 (s, 1H, -NH-); 9.3 (s, 1H, -NH-); 8.6 (s, 1H, -OH); 7.2 to 8.0 (m, 13H, Ar-H); 7.0 (d, β lactum 2H – Proton); 3.6 (s, 3H, -OCH ); MS (m/z) 634 (M+) 517.5, 379.4, 201.3, Analysis Calcd. for C H O SN FCl; C, 56.83%; H, 3.34%; N, 11.05%; Found; C, 56.81%; H,
3.32%; N, 11.01%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-o-chloroanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3- chloro azetidin–2–one (A4). Yield 72%; mp 164oC; IR
Available online at www.ignited.in Page 4
(KBr) ν (cm-1); 3380 (Ar-NH); 1730 (C=0); 1540 (C=N); 1680 (C=C); 1155 (C-F); 720 (C–S); 1300 (Sec.Ar.Amine); 850 (C–Cl); 1250 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.6 (s, 1H, -NH-); 9.4 (s, 1H, -NH-); 8.6 (s, 1H, -OH); 7.0 to 7.8 (m, 13H, Ar-H); 6.9 (d, β lactum 2H – Proton); 3.8 (s, 3H, -OCH3); Analysis Calcd. for C30H22O4S2N4FCl; C, 57.79%; H, 3.39%; N, 8.99%; Found; C, 57.73%; H, 3.35%; N, 8.92%. 4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-m- chloroanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-
3- chloro azetidin–2–one (A5). Yield 74%; mp 132oC; IR (KBr) ν (cm-1); 3400 (Ar-NH); 1765 (C=0); 1540 (C=N); 1690 (C=C); 1170 (C-F); 725 (C–S); 1310 (Sec.Ar.Amine); 820 (C–Cl); 1250 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.3 (s, 1H, -NH-); 9.0 (s, 1H, -NH-); 8.6 (s, 1H, -OH); 7.2 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, - OCH3); Analysis Calcd. for C30H22O4S2N4FCl; C, 57.79%; H, 3.39%; N, 8.99%; Found; C, 57.72%; H,
3.33%; N, 8.96%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-p-chloroanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3- chloro azetidin–2–one (A6). Yield 73%; mp 126oC; IR (KBr) ν (cm-1); 3290 (Ar-NH); 1720 (C=0); 1530 (C=N); 1680 (C=C); 1160 (C-F); 725 (C–S); 1300 (Sec.Ar.Amine); 840 (C–Cl); 1250 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.5 (s, 1H, -NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.7 (s, 3H, - OCH3); MS (m/z) 634 (M ) 613.9, 454.7, 369.8, 203.8; Analysis Calcd. for C30H22O4S2N4FCl; C, 57.79%; H, 3.39%; N, 8.99%; Found; C, 57.74%; H, 3.36%; N, 8.94%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'- anilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3-
chloro azetidin–2–one (A7). Yield 76%; mp 112oC; IR (KBr) ν (cm-1); 3390 (Ar-NH); 1755 (C=0); 1510 (C=N); 1690 (C=C); 1150 (C-F); 720 (C–S); 1255 (Sec.Ar.Amine); 840 (C–Cl); 1220 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.6 (s, 1H, - NH-); 9.2 (s, 1H, -NH-); 8.2 (s, 1H, -OH); 7.4 to 8.2 (m, 14H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.6 (s, 3H, -OCH3); Analysis Calcd. for C30H22O4S2N4FCl; C, 61.17%; H, 3.76%; N, 9.51%; Found; C, 61.14%; H, 3.72%;
N, 9.46%. 4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'- o- methoxyanilino (1,3) - benzothiazol-2'-yl) amido-2-
phenyl]-3- chloroazetidin–2–one (A8). Yield 65%; mp 124oC; IR (KBr) ν (cm-1); 3350 (Ar-NH); 1720 (C=0); 1540
(C=N); 1685 (C=C); 1165 (C-F); 725 (C–S); 1310
(Sec.Ar.Amine); 830 (C–Cl); 1250 (C-O-C); 1390 (Ar-OH); 1H NMR (CDCl ) δ 9.5 (s, 1H, -NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, -OCH3); 3.6 (s, 3H, -OCH3); Analysis Calcd. for C31H24O5SN4FCl;C, 60.14%; H, 3.91%; N, 9.05%; Found; C, 60.13%; H, 3.87%; N, 9.01%.
4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'- m –
methoxyanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]- 3-chloroazetidin–2–one (A9). Yield 69%; mp 118oC; IR (KBr) ν (cm-1); 3310 (Ar-NH); 1730 (C=0); 1550 (C=N); 1650 (C=C); 1130 (C-F); 725 (C–S); 1310 (Sec.Ar.Amine); 840 (C–Cl); 1245 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.5 (s, 1H,-NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, - OCH3); 3.6 (s, 3H, -OCH3); 6.4 (d, β lactum 2H – Proton); Analysis Calcd. For C31H24O5SN4FCl; C, 60.14%; H, 3.91%; N, 9.05%; Found; C, 60.12%; H, 3.88%; N, 9.02%. 4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'- p - methoxyanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]- 3-chloroazetidin–2–one (A10). Yield 83%; mp 158oC; IR (KBr) ν (cm-1); 3400 (Ar-NH); 1750 (C=0); 1560 (C=N); 1660 (C=C); 1170 (C-F); 730 (C–S); 1300 (Sec.Ar.Amine); 850 (C–Cl); 1230 (C-O-C); 1385 (Ar-OH); 1H NMR (CDCl ) δ 9.5 (s, 1H, -NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, -OCH3); 3.6 (s, 3H, -OCH3); Analysis Calcd. for C31H22O6SN4FCl;C, 60.14%; H, 3.91%; N, 9.05%; Found; C, 60.11%; H, 3.89%; N, 9.01%. 4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'- p – carboxyanilino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3- chloroazetidin–2–one (A11). Yield 77%; mp 260oC; IR (KBr) ν (cm-1); 3320 (Ar-NH); 1700 (C=0); 1530 (C=N); 1640 (C=C); 1165 (C-F); 730 (C–S); 1310 (Sec.Ar.Amine); 840 (C–Cl); 1270 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 10.2 ( s, 1H, -COOH); 9.5 (s, 1H, -NH-); 9.2 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 13H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, -OCH3); 3.6 (s, 3H, -OCH3); Analysis Calcd. for C31H22O6SN4FCl; C, 58.82%; H, 3.50%; N, 8.85%; Found; C, 58.77%; H, 3.47%; N, 8.82%. 4-(m-hydroxy-p-methoxy phenyl)-1-[(6'-fluoro-7'-piperzino (1,3)-benzothiazol-2'-yl) amido-2-phenyl]-3- chloroazetidin–2–one (A12). Yield 85%; mp 308oC; IR (KBr) ν (cm-1); 3300 (Ar-NH); 1650 (C=0); 1550 (C=N); 1650 (C=C); 1190 (C-F); 740 (C–S); 1290 (Sec.Ar.Amine); 850 (C–Cl); 1290 (C-O-C); 1380 (Ar-OH); 1H NMR (CDCl ) δ 9.5 (s, 1H, -NH-); 8.4 (s, 1H, -OH); 7.0 to 8.0 (m, 9H, Ar-H); 6.8 (d, β lactum 2H – Proton); 3.8 (s, 3H, -OCH3); 2.6 (t, 4H, (CH2)2); 2.4 (t, 4H, (CH2)2); Analysis Calcd. for C30H22O4S2N4FCl; C, 57.78%; H, 4.33%; N, 12.03%; Found; C, 57.74%; H, 4.30%; N, 12.81%.
Available online at www.ignited.in Page 5
IN- VITRO ANTHELMINTIC STUDY
The synthesized compounds are screened for anthelmintic activity by using earthworms, Perituma posthuma [13]. Six earthworms of nearly equal size were placed in standard drug solution and test compound’s solutions at room temperature. Normal saline used as control. The standard drug and test compounds were dissolved in minimum quantity of dimethyl formamide (DMF) and adjusted the volume up to 15 ml with normal saline solution to get the concentration of 0.1 % w/v, 0.2 % w/v and 0.5% w/v. Albendazole was used as a standard drug [14]. The compounds were evaluated by the time taken for complete paralysis and death of earthworms. The mean lethal time for each test compound was recorded and compared with standard drug. The time taken by worms to become motionless was noted as paralysis time. To ascertain the death of the motionless worms were frequently applied with external stimuli, which stimulate and induce movement in the worms, if alive. The mean lethal time and paralysis time of the earthworms for different test compounds and standard drug are tabulated (Table no. 1). Table No-1. Anthelmintic activity
Sl.
No. Name
Time in Minutes For Paralysis For Death % of Concentration % of Concentration
0.1 0.2 0.5 0.1 0.2 0.5 01 Control (0.9 % Concentration)
-- -- -- -- -- --
02 Albendazole 9.0 9.0 4.0 10.0 10.0 8.0
03 A1 9.0 9.0 7.0 13.0 15.0 16.0 04 A2 9.0 8.0 4.0 16.0 15.0 9.0 05 A3 2.0 1.0 1.0 13.0 13.0 11.0 06 A4 9.0 9.0 5.0 16.0 14.0 9.0 07 A5 8.0 8.0 7.0 23.0 20.0 15.0 08 A6 8.0 7.0 5.0 19.0 17.0 12.0 09 A7 6.0 5.0 4.0 17.0 15.0 8.0 10 A8 12.0 6.0 5.0 17.0 15.0 12.0 11 A9 8.0 6.0 5.0 18.0 14.0 7.0 12 A10 9.0 8.0 4.0 13.0 12.0 8.0 13 A11 2.0 2.0 1.0 9.0 8.0 3.0 14 A12 11.0 11.0 6.0 21.0 17.0 13.0
Activity Index = Test Compound / Standard compound
RESULTS AND DISCUSSION
Synthesized compounds of 4(m-hydroxy-p-methoxy phenyl)-1[(6'-fluoro-7'-substituted (1,3)-benzothiazol- 2'-yl) amido-2-phenyl] 3-chloro azetidin–2–one were tested for
anthelmintic activity against earthworms, Perituma
posthuma compared to standard albendazole. A3, A7, A9 and A11 showed significant activity compared to standard albendazole.
CONCLUSION
Result of present study demonstrate that, a new class of different aromatic primary and secondary amines encompassing azetidinone to get targeted molecules were synthesized and evaluated for anthelmintic activity. The newly synthesized heterocyclics exhibited promising anthelmintic activity against earthworms, Perituma posthuma at low and high concentration compared to standard Albendazole. It can be concluded that this class of compounds certainly holds great promise towards good active leads in medicinal chemistry. A further study to acquire more information concerning pharmacological activity is in progress.
REFERENCES
[1] R Filler. J Fluorine Chem 1986; 33: 361-375. [2] V Sutoris, J Halgas. Chem Abstr 1984;100: 103234 s. [3] Ares Jaffrey. Chem Abstr 1991;114: 71453 d. [4] OW Wollesdrof Jr, H Schwam. Chem Abstr 1989; 111: 194656 x. [5] E Costakes, G Tsatsas. Chem Abstr 1979; 90: 203935 q. [6] D Sreenivasa Rao, E Jayachandran, GM Sreenivasa, B Shivakumar. Oriental J Chem 2005; 21(1): 113-116. [7] GM Sreenivasa, B Shivkumar, E Jayachandran. Indian Drugs 2006;43 (4): (2006). [8] RA Turner. Anti-epileptic drugs, in screening methods in pharmacology, XV edn. (Ed. Turner RA), Academic Press, New York, 1965, pp. 165-172. [9] VP. Chernykh, OF Sidorenko. Chem Abstr 1983; 98: 89233 x. [10] L Conte et al. J Fluorine Chem 1995; 70: 175-179. [11] Desbois Michel, Eur Pat. Chem Abstr 1987; 108:
Available online at www.ignited.in Page 6
159896 a. [12] Biological assays. Indian Pharmacopoeia Published by Govt. of India, 2: 88 (1996). [13] E Jayachandran, K Bhatia, LVG Nargund, A Roy. Indian Drugs 2003; 40 (7). [14] S Bushan Kumar Sathe, GM. Sreenivasa, E Jayachandran, D Sreenivasa Rao, LVG Nargund. Int J Chem Sci 2006; 4 (3): 545-552.